Ameritox competitors

Serial entrepreneur, board member and strategist. Particular knowledge in diagnostics and healthcare services.

Alan Greenberg is a Chief Executive Officer and President at Sunrise Medical Laboratories and is based in Plainview, New York. He has worked as Chief Financial Officer at Sunrise Medical Laboratories and Sonic Healthcare USA-Northeast and Controller at QUEST DIAGNOSTICS INC.

Bob Garvey is a Chief Executive Officer at Dominion Diagnostics and is based in North Kingstown, Rhode Island. He has worked as Various at GE Healthcare; VP Sales and Marketing at QUEST DIAGNOSTICS INC; and Sales Rep, Sales Supervisor, District Sales Manager at Ricoh Australia. Bob attended WOBURN HIGH SCHOOL between 1980 and 1984 and University of Massachusetts, Lowell between 1984 and 1988.

Jake Orville has 20+ years of diagnostic, life science and medical device management experience within both established and emerging markets. As the General Manager of Pipeline at Exact Sciences, Jake leads the company's efforts to develop and advance solutions for earlier detection and life changing answers across the cancer continuum. Prior to Exact Sciences, Jake co-founded Cleveland HeartLab, Inc. (CHL) and served as the CEO from inception to exit. CHL was spun-out of the Cleveland Clinic to develop and rapidly commercialize unique diagnostic technologies, with applications in cardiovascular and inflammatory indications. CHL was acquired by Quest Diagnostics in December 2017. Jake Served as the General Manager of the Cardiometabolic & Endocrinology Franchise at Quest. Under Jake’s leadership, CHL was recognized as Ohio’s Venture of the Year (2012); received an Economic Impact Award by the city of Cleveland for job creation (2013) and was recognized as an Inc. 500 fastest growing private company in the US (2014). Jake has been recognized as a Top 50 Smart Leader by Smart Magazine and received the Annual Innovation Award in 2018 Prior to co-founding Cleveland HeartLab, Jake was CEO of Prognostix and held Senior Management positions with two publically traded companies (NextGen Sciences - AIM NGG.L; Third Wave Technologies - Nasdaq TWTI). He is a co-founder of Viridian Medical and Tolera Therapeutics and currently sits on the Board of Directors for The Wisconsin Women’s Health Foundation. Jake has raised capital from multiple sources, including top tier venture funds, strategic and international investors as well as angels, family offices and state funding sources. A well recognized entrepreneur, he has given many lectures on innovation, commercialization, early stage ventures, technology transfer and intellectual property. Jake received his Bachelor of Arts from the University of Massachusetts, Amherst and his MBA from the University of Wisconsin, Madison.